Armata Pharmaceuticals (ARMP) EBIT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.47% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -12.10% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.35% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 55.96% |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 8.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.17% |
| Dec 31, 2025 | -10.20% |
| Sep 30, 2025 | 3.39% |
| Jun 30, 2025 | 9.46% |
| Mar 31, 2025 | 2.27% |
| Dec 31, 2024 | -20.34% |
| Sep 30, 2024 | -16.67% |
| Jun 30, 2024 | -24.35% |
| Mar 31, 2024 | -23.46% |
| Dec 31, 2023 | -14.07% |
| Sep 30, 2023 | -22.50% |
| Jun 30, 2023 | -28.01% |
| Mar 31, 2023 | -32.11% |
| Dec 31, 2022 | -33.14% |
| Sep 30, 2022 | -8.36% |
| Jun 30, 2022 | -21.36% |
| Mar 31, 2022 | -36.62% |
| Dec 31, 2021 | -29.36% |
| Sep 30, 2021 | -36.24% |
| Jun 30, 2021 | -29.65% |
| Mar 31, 2021 | -21.17% |
| Dec 31, 2020 | -39.74% |
| Sep 30, 2020 | -96.07% |
| Jun 30, 2020 | 22.04% |
| Mar 31, 2020 | -13.57% |
| Dec 31, 2019 | 28.28% |
| Sep 30, 2019 | -25.76% |
| Jun 30, 2019 | -12.85% |
| Mar 31, 2019 | 8.68% |
| Dec 31, 2018 | 1.68% |
| Sep 30, 2018 | -0.01% |
| Jun 30, 2018 | -3.13% |
| Mar 31, 2018 | -10.46% |
| Dec 31, 2017 | 3.07% |
| Sep 30, 2017 | 47.75% |
| Jun 30, 2017 | -37.23% |
| Mar 31, 2017 | -9.85% |
| Dec 31, 2016 | -66.16% |
| Sep 30, 2016 | -13.32% |
| Jun 30, 2016 | 16.32% |